Novel biomaterial approaches to develop implants that can deliver macromolecules and optimize for dose frequency with representatives from AbbVie, Novartis, Pendant Biosciences, Pfizer and Thermo Fisher Scientific.
Novel biomaterial approaches to develop implants that can deliver macromolecules and optimize for dose frequency with representatives from AbbVie, Novartis, Pendant Biosciences, Pfizer and Thermo Fisher Scientific.